With issues in therapy delivery and a barren trial landscape, short-term chances for a commercial galactosemia treatment are ...
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...
Discover how a novel nasal spray could revolutionize traumatic brain injury treatment by reducing neuroinflammation and ...
Ocrelizumab treatment in Black and Hispanic patients with MS reduces NfL levels and prevents the forming of contrast-enhancing lesions and new or enlarging T2 lesions.
Ozanimod treatment for early relapsing multiple sclerosis helps prevent impaired cognitive functioning during the first year of use.
Understanding the Challenges of Alzheimer’s Disease Alzheimer’s disease doesn’t just impact the person diagnosed—it affects ...
The nameless disease is neurodegenerative, which means it has no cure, and Ireland could face a gradual decline in her ...
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...
A young woman from Wolverhampton, Talia Sinnott, is urgently appealing for community support to fund a life-changing medical ...
There are several situations where it's advisable to consult a doctor.
Could a social media post really solve years of confusion? Friedrich's Ataxia is a rare disease that only affects 1-in-50,000 people. "Looking at the way this girl moved — the unsteadiness and ...